Thrombin generation and bleeding in cardiac surgery: a clinical narrative review
- 4 March 2020
- journal article
- review article
- Published by Springer Nature in Canadian Journal of Anesthesia/Journal canadien d'anesthésie
- Vol. 67 (6) , 746-753
Abstract
This narrative review discusses the role of thrombin generation in coagulation and bleeding in cardiac surgery, the laboratory methods for clinical detection of impaired thrombin generation, and the available hemostatic interventions that can be used to improve thrombin generation. Coagulopathy after cardiopulmonary bypass (CPB) is associated with excessive blood loss and adverse patient outcomes. Thrombin plays a crucial role in primary hemostasis, and impaired thrombin generation can be an important cause of post-CPB coagulopathy. Existing coagulation assays have significant limitations in assessing thrombin generation, but whole-blood assays designed to measure thrombin generation at the bed-side are under development. Until then, clinicians may need to institute therapy empirically for non-surgical bleeding in the setting of normal coagulation measures. Available therapies for impaired thrombin generation include administration of plasma, prothrombin complex concentrate, and bypassing agents (recombinant activated factor VII and factor eight inhibitor bypassing activity). In vitro experiments have explored the relative potency of these therapies, but clinical studies are lacking. The potential incorporation of thrombin generation assays into clinical practice and treatment algorithms for impaired thrombin generation must await further clinical development.Keywords
This publication has 65 references indexed in Scilit:
- Preoperative thrombin generation is predictive for the risk of blood loss after cardiac surgery: a research articleJournal of Cardiothoracic Surgery, 2013
- Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleedingJournal of Thrombosis and Haemostasis, 2011
- Prothrombin complex concentrate mitigates diffuse bleeding after cardiopulmonary bypass in a porcine modelBritish Journal of Anaesthesia, 2010
- Factor Eight Inhibitor Bypassing Activity (FEIBA) for Refractory Bleeding in Cardiac Surgery: Review of Clinical OutcomesJournal of Cardiac Surgery, 2008
- Thrombin generation, fibrin clot formation and hemostasisTransfusion and Apheresis Science, 2008
- Investigation of the thrombin‐generating capacity, evaluated by thrombogram, and clot formation evaluated by thrombelastography of platelets stored in the blood bank for up to 7 daysVox Sanguinis, 2007
- Thrombin generation and fibrin clot structureBlood Reviews, 2007
- A Cell-Based Model of Thrombin GenerationSeminars in Thrombosis and Hemostasis, 2006
- Thrombin generation, a function test of the haemostaticthrombotic systemThrombosis and Haemostasis, 2006
- Thrombin and cardiopulmonary bypass – A paradigm for evaluation of the regulation of hemostasisInternational Journal of Angiology, 2005